Share this article:
Mark Straley, CEO, Agendia

Mark Straley, CEO, Agendia

Get the latest OC business updates for FREE

Agendia Inc., an Irvine-based provider of genomic breast cancer tests, is seeking to raise $75 million in an initial public offering, according to an Oct. 28 filing with the Securities and Exchange Commission.

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in Orange County
  • NEW: Orange County 500 — influential business leaders you need to know
Yours for only $99

For digital licensing requests for this article, Contact Kim Lopez